These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9814943)

  • 1. HIV vaccine development for the world: an idea whose time has come?
    Berkley S
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S191-6. PubMed ID: 9814943
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives.
    Hecht R; Suraratdecha C
    PLoS Med; 2006 Sep; 3(10):e398. PubMed ID: 16953657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the science. HIV vaccine development.
    Grady C; Kelly G
    Nurs Clin North Am; 1996 Mar; 31(1):25-39. PubMed ID: 8604385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. medical research in the developing world: ignoring Nuremberg.
    Roman J
    Cornell J Law Public Policy; 2002; 11(2):441-60. PubMed ID: 12058774
    [No Abstract]   [Full Text] [Related]  

  • 5. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
    Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparations for AIDS vaccine evaluations. AIDS International Training and Research Program.
    Bridbord K
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S227-9. PubMed ID: 7865307
    [No Abstract]   [Full Text] [Related]  

  • 8. [HIV infection has become treatable: a medical success that helps only a few].
    MMW Fortschr Med; 2006 Oct; 148(42):19. PubMed ID: 17621793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic and preventive vaccine against HIV problems and the necessity to develop one].
    García F
    Rev Enferm; 2005 Dec; 28(12):24-8. PubMed ID: 16459877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of an AIDS vaccine in developing countries: a new model and initial results.
    Stover J; Bollinger L; Hecht R; Williams C; Roca E
    Health Aff (Millwood); 2007; 26(4):1147-58. PubMed ID: 17630459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL; Hahn BH
    AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons for AIDS vaccine development from non-AIDS vaccines.
    Clements-Mann ML
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S197-203. PubMed ID: 9814944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold shower for AIDS vaccines.
    Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
    [No Abstract]   [Full Text] [Related]  

  • 15. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
    Yearby R
    De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692
    [No Abstract]   [Full Text] [Related]  

  • 16. Human immunodeficiency virus vaccine development in developing countries: are efficacy trials feasible?
    Excler JL; Beyrer C
    J Hum Virol; 2000; 3(4):193-214. PubMed ID: 10990167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges of HIV vaccine development and testing.
    Burgers WA; Williamson C
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV vaccine research in Thailand: lessons learned.
    Pitisuttithum P
    Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccines against HIV].
    Holm-Hansen C
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.